SHORT syndrome in two Chinese girls: A case report and review of the literature

• Main Authors: Yanhong Zhang, Baolan Ji, Jinsheng Li, Yanying Li, Mei Zhang, Bo Ban
• Format: Article
• Language: English
• Published: Wiley 2020-09-01
• Series: Molecular Genetics & Genomic Medicine
• Subjects: diabetes; insulin resistance; PIK3R1; short stature; SHORT syndrome; whole exome sequencing
• Online Access: https://doi.org/10.1002/mgg3.1385

Abstract Background SHORT syndrome is a rare inherited multisystem disease that includes characteristic facial features, growth retardation, and metabolic anomalies and is related to heterozygous mutations in the PIK3R1 gene. However, it is difficult to ascertain the relationship between the phenotype and the genotype quickly and efficiently. Methods We report two Chinese girls with SHORT syndrome who presented with growth retardation, dysmorphic features, insulin resistance, and diabetes. Comprehensive medical evaluations were collected, including anthropometric measurements, laboratory measurements, and imaging examinations. Whole exome and Sanger sequencing was performed to detect and confirm the underlying genetic mutations in these patients. We prescribed metformin for the patients. Results The patients both presented diabetes, insulin resistance, short stature, lipodystrophy, and characteristic facial dysmorphic features. A heterozygous mutation was detected in the PIK3R1 gene (c.1615_1617del) of Patient 1. The analysis of patient 2 revealed another PIK3R1 mutation (c.1945C>T). After family validation, neither their parents nor their brothers had similar clinical presentations or carried the same mutation. Conclusion We identified two de novo heterozygous mutations in PIK3R1 as the cause of SHORT syndrome in two Chinese girls. Additionally, in terms of diabetes control, metformin works well in the early treatment stage.